Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx

Glycobiology

Volumn 26, Issue 10, 2016, Pages 1120-1132

  McMorran, Brian J ^a   McCarthy, Francis E ^a   Gibbs, Elizabeth M ^b   Pang, Mabel ^a   Marshall, Jamie L ^c   Nairn, Alison V ^d   Moremen, Kelley W ^d   Crosbie Watson, Rachelle H ^b   Baum, Linda G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d NONE   (United States)

Author keywords

GalNAc; muscle glycosylation; neuromuscular junction; utrophin glycoprotein complex; Wisteria floribunda agglutinin

Indexed keywords

AGGLUTININ; DOLICHOS BIFLORUS AGGLUTININ; EPITOPE; GLYCAN; GLYCOSIDASE; SMALL INTERFERING RNA; SOYBEAN AGGLUTININ; UNCLASSIFIED DRUG; VICIA VILLOSA AGGLUTININ; WISTERIA FLORIBUNDA AGGLUTININ; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; BIOTINYLATION; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; GLYCOCALYX; GLYCOSYLATION; LECTIN BINDING; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOTUBE; NEUROMUSCULAR JUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; SECRETORY PATHWAY; SKELETAL MUSCLE CELL; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; CHICKEN; CYTOLOGY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHICKENS; EPITOPES; GLYCOCALYX; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; POLYSACCHARIDES;

EID: 84994851399     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cww061     Document Type: Article

References (52)

1. Abbott KL, Nairn AV, Hall EM, Horton MB, McDonald JF, Moremen KW, Dinulescu DM, Pierce M. 2008. Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics. 8:3210-3220.
2. Amenta AR, Yilmaz A, Bogdanovich S, McKechnie BA, Abedi M, Khurana TS, Fallon JR. 2011. Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci USA. 108:762-767.
3. Burkin DJ, Kaufman SJ. 1999. The alpha7beta1 integrin in muscle development and disease. Cell Tissue Res. 296:183-190.
4. Cabrera PV, Amano M, Mitoma J, Chan J, Said J, Fukuda M, Baum LG. 2006. Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death. Blood. 108:2399-2406.
5. Cabrera PV, Pang M, Marshall JL, Kung R, Nelson SF, Stalnaker SH, Wells L, Crosbie-Watson RH, Baum LG. 2012. High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding. J Biol Chem. 287:22759-22770.
6. Chandrasekharan K, Yoon JH, Xu Y, deVries S, Camboni M, Janssen PM, Varki A, Martin PT. 2010. A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med. 2:42ra54.
7. Chou HH, Takematsu H, Diaz S, Iber J, Nickerson E, Wright KL, Muchmore EA, Nelson DL, Warren ST, Varki A. 1998. A mutation in human CMPsialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA. 95:11751-11756.
8. Chu FK. 1986. Requirements of cleavage of high mannose oligosaccharides in glycoproteins by peptide N-glycosidase F. J Biol Chem. 261:172-177.
9. Clerk A, Morris GE, Dubowitz V, Davies KE, Sewry CA. 1993. Dystrophinrelated protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem J. 25:554-561.
10. Cummings RD, Kornfeld S. 1982. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J Biol Chem. 257:11230-11234.
11. Endo T. 2015. Glycobiology of α-dystroglycan and muscular dystrophy. J Biochem. 157:1-12.
12. Ervasti JM, Burwell AL, Geissler AL. 1997. Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation. Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin b4 masked by sialic acid modification. J Biol Chem. 272:22315-22321.
13. Ervasti JM, Campbell KP. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 122:809-823.
14. Fuhrmann U, Bause E, Legler G, Ploegh H. 1984. Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides. Nature. 307:755-758.
15. Gasimli L, Hickey AM, Yang B, Li G, dela Rosa M, Nairn AV, Kulik MJ, Dordick JS, Moremen KW, Dalton S, et al. 2014. Changes in glycosaminoglycan structure on differentiation of human embryonic stem cells towards mesoderm and endoderm lineages. Biochim Biophys Acta. 1840:1993-2003.
16. Greenaway PJ, LeVine D. 1973. Binding of N-acetyl-neuraminic acid by wheat-germ agglutinin. Nat New Biol. 241:191-192.
17. Gundry RL, Raginski K, Tarasova Y, Tchernyshyov I, Bausch-Fluck D, Elliott ST, Boheler KR, Van Eyk JE, Wollscheid B. 2009. The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation. Mol Cell Proteomics. 8:2555-2569.
18. Hedberg C, Oldfors A, Darin N. 2014. B3GALNT2 is a gene associated with congenital muscular dystrophy with brain malformations. Eur J Hum Genet. 22:707-710.
19. Iwata Y, Suzuki O, Wakabayashi S. 2013. Decreased surface sialic acid content is a sensitive indicator of muscle damage. Muscle Nerve. 47:372-378.
20. James M, Simmons C, Wise CJ, Jones GE, Morris GE. 1995. Evidence for a utrophin-glycoprotein complex in cultured cell lines and a possible role in cell adhesion. Biochem Soc Trans. 23:398S.
21. Kanagawa M, Michele DE, Satz JS, Barresi R, Kusano H, Sasaki T, Timpl R, Henry MD, Campbell KP. 2005. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. FEBS Lett. 579:4792-4796.
22. Konami Y, Yamamoto K, Osawa T, Irimura T. 1994. Strong affinity of Maackia amurensis hemagglutinin (MAH) for sialic acid-containing Ser/ Thr-linked carbohydrate chains of N-terminal octapeptides from human glycophorin A. FEBS Lett. 342:334-338.
23. Lee EU, Roth J, Paulson JC. 1989. Alteration of terminal glycosylation sequences on N-linked oligosaccharides of Chinese hamster ovary cells by expression of beta-galactoside alpha 2, 6-sialyltransferase. J Biol Chem. 264:13848-13855.
24. Live D, Wells L, Boons GJ. 2013. Dissecting the molecular basis of the role of the O-mannosylation pathway in disease: α-dystroglycan and forms of muscular dystrophy. Chembiochem. 14:2392-2402.
25. Lotan R, Skutelsky E, Danon D, Sharon N. 1975. The purification, composition, and specificity of the anti-T lectin from peanut (Arachis hypogaea). J Biol Chem. 250:8518-8523.
26. Magalhães A, Marcos-Pinto R, Nairn AV, Dela Rosa M, Ferreira RM, Junqueira-Neto S, Freitas D, Gomes J, Oliveira P, Santos MR, et al. 2015. Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways. Biochim Biophys Acta. 1852:1928-1939.
27. Marshall JL, Holmberg J, Chou E, Ocampo AC, Oh J, Lee J, Peter AK, Martin PT, Crosbie-Watson RH. 2012. Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration. J Cell Biol. 197:1009-1027.
28. Martin PT, Camboni M, Xu R, Golden B, Chandrasekharan K, Wang CM, Varki A, Janssen PM. 2013. N-Glycolylneuraminic acid deficiency worsens cardiac and skeletal muscle pathophysiology in α-sarcoglycan-deficient mice. Glycobiology. 23:833-843.
29. Martin PT, Kaufman SJ, Kramer RH, Sanes JR. 1996. Synaptic integrins in developing, adult, and mutant muscle: selective association of alpha1, alpha7A, and alpha7B integrins with the neuromuscular junction. Dev Biol. 174:125-139.
30. McDearmon EL, Combs AC, Ervasti JM. 2001. Differential Vicia villosa agglutinin reactivity identifies three distinct dystroglycan complexes in skeletal muscle. J Biol Chem. 276:35078-35086.
31. Mega T, Oku H, Hase S. 1992. Characterization of carbohydrate-binding specificity of concanavalin A by competitive binding of pyridylamino sugar chains. J Biochem. 111:396-400.
32. Meier T, Ruegg MA. 2000. The role of dystroglycan and its ligands in physiology and disease. News Physiol Sci. 15:255-259.
33. Monti E, Preti A, Nesti C, Ballabio A, Borsani G. 1999. Expression of a novel human sialidase encoded by the NEU2 gene. Glycobiology. 9:1313-1321.
34. Nairn AV, York WS, Harris K, Hall EM, Pierce JM, Moremen KW. 2008. Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J Biol Chem. 283:17298-17313.
35. Nguyen HH, Jayasinha V, Xia B, Hoyte K, Martin PT. 2002. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc Natl Acad Sci USA. 99:5616-5621.
36. Patnaik SK, Stanley P. 2005. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding. J Biol Chem. 280:20851-20859.
37. Praissman JL, Live DH, Wang S, Ramiah A, Chinoy ZS, Boons GJ, Moremen KW, Wells L. 2014. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan. Elife. 3. DOI:10.7554/eLife.03943.
38. Praissman JL, Willer T, Sheikh MO, Toi A, Chitayat D, Lin YY, Lee H, Stalnaker SH, Wang S, Prabhakar PK, et al. 2016. The functional Omannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition. Elife. 5. DOI:10.7554/eLife.14473.
39. Sanes JR, Cheney JM. 1982. Lectin binding reveals a synapse-specific carbohydrate in skeletal muscle. Nature. 300:646-647.
40. Scott LJ, Bacou F, Sanes JR. 1988. A synapse-specific carbohydrate at the neuromuscular junction: association with both acetylcholinesterase and a glycolipid. J Neurosci. 8:932-944.
41. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. 1987. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem. 262:1596-1601.
42. Song WK, Wang W, Foster RF, Bielser DA, Kaufman SJ. 1992. H36-alpha 7 is a novel integrin alpha chain that is developmentally regulated during skeletal myogenesis. J Cell Biol. 117:643-657.
43. Stevens E, Carss KJ, Cirak S, Foley AR, Torelli S, Willer T, Tambunan DE, Yau S, Brodd L, Sewry CA, et al. 2013. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Am J Hum Genet. 92:354-365.
44. Tidball JG. 1991. Force transmission across muscle cell membranes. J Biomech. 24(Suppl 1):43-52.
45. Tintignac LA, Brenner HR, Rüegg MA. 2015. Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting. Physiol Rev. 95:809-852.
46. Van Ry PM, Wuebbles RD, Key M, Burkin DJ. 2015. Galectin-1 protein therapy prevents pathology and improves muscle function in the mdx mouse model of Duchenne muscular dystrophy. Mol Ther. 23:1285-1297.
47. von der Mark H, Williams I, Wendler O, Sorokin L, von der Mark K, Pöschl E. 2002. Alternative splice variants of alpha 7 beta 1 integrin selectively recognize different laminin isoforms. J Biol Chem. 277:6012-6016.
48. Willer T, Inamori K, Venzke D, Harvey C, Morgensen G, Hara Y, Beltrán Valero de Bernabé D, Yu L, Wright KM, et al. 2014. The glucuronyltransferase B4GAT1 is required for initiation of LARGEmediated α-dystroglycan functional glycosylation. Elife. 3. DOI:10.7554/eLife.03941.
49. Wu AM, Wu JH, Lin LH, Lin SH, Liu JH. 2003. Binding profile of Artocarpus integrifolia agglutinin (Jacalin). Life Sci. 72:2285-2302.
50. Xia B, Hoyte K, Kammesheidt A, Deerinck T, Ellisman M, Martin PT. 2002. Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. Dev Biol. 242:58-73.
51. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, MadsonM, Oldstone MB, Schachter H, Wells L, Campbell KP. 2010. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science. 327:88-92.
52. Zhang P, Hu H. 2012. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase. Glycobiology. 22:235-247.